【24h】

Antenatal Corticosteroid Therapy for Fetal Maturation

机译:胎儿成熟的产前皮质类固醇疗法

获取原文
获取原文并翻译 | 示例
       

摘要

A single course of corticosteroids is recommended for all pregnant women between 24 and 34 weeks of gestation who are at risk of preterm delivery within 7 days. A single course of antenatal corticosteroids should be administered to women with premature rupture of membranes (PROM) before 32 weeks of gestation to reduce the risks of respiratory distress syndrome, perinatal mortality, and other morbidities. The efficacy of corticosteroid use at 32-33 completed weeks of gestation for preterm PROM is unclear based on available evidence, but treatment may be beneficial, particularly if pulmonary immaturity is documented. No data exist on the efficacy of corticosteroid use before viability, and such use is not recommended at this time. Because of insufficient scientific evidence, repeat corticosteroid courses, including so-called "rescue therapy," should not be used routinely but should be reserved for women enrolled in clinical trials.
机译:建议所有妊娠24至34周之间且有可能在7天内提前分娩的孕妇单次服用皮质类固醇。胎膜早破(PROM)的妇女应在妊娠32周之前服用一疗程的皮质类固醇激素,以减少呼吸窘迫综合征,围产期死亡率和其他疾病的风险。根据现有证据,在妊娠32-33周完成时使用皮质类固醇对早产PROM的疗效尚不清楚,但治疗可能是有益的,尤其是在有肺不成熟的情况下。尚无生存前使用皮质类固醇激素的疗效数据,目前不建议使用。由于科学证据不足,不应常规使用重复的皮质类固醇疗程,包括所谓的“抢救疗法”,而应留给参加临床试验的女性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号